Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

JOURNAL ARTICLE published December 2022 in Journal of Cardiovascular Pharmacology

Authors: Erik Duijvelaar | Arthur Vanhove | Job R. Schippers | Patrick J. Smeele | Frances S. de Man | Yigal Pinto | Jurjan Aman | Harm Jan Bogaard | CounterCOVID Collaborative Group